Chromosomal location of the fosA3 and blaCTX-M genes in Proteus mirabilis and clonal spread of Escherichia coli ST117 carrying fosA3-positive IncHI2/ST3 or F2:A-:B- plasmids in a chicken farm

International Journal of Antimicrobial Agents

Volumn 49, Issue 4, 2017, Pages 443-448

  He, Dandan ^a   Liu, Lanping ^a   Guo, Baowei ^a   Wu, Shengjun ^a   Chen, Xiaojie ^a   Wang, Jing ^a   Zeng, Zhenling ^a   Liu, Jian Hua ^a  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

CTX M; Escherichia coli; Fosfomycin; Plasmid; Poultry; Proteus mirabilis

Indexed keywords

AMIKACIN; AMPICILLIN; APRAMYCIN; CEFOTAXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; FLORFENICOL; FOSFOMYCIN; GENTAMICIN; NEOMYCIN; STREPTOMYCIN; TETRACYCLINE; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BLACTX M 14 GENE; BLACTX M 3 GENE; BLACTX M 65 GENE; BLATEM 1 GENE; CLONING; ESCHERICHIA COLI; FOSA3 GENE; GENE STRUCTURE; GENOTYPE; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PLASMID; POULTRY FARMING; PROTEUS MIRABILIS; PULSED FIELD GEL ELECTROPHORESIS; AGRICULTURAL LAND; ANALYSIS; ANIMAL; CHICKEN; CLASSIFICATION; ENTEROBACTERIACEAE INFECTION; GENETICS; HETEROZYGOTE; HORIZONTAL GENE TRANSFER; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; VETERINARY;

ANIMALS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARRIER STATE; CHICKENS; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FARMS; GENE TRANSFER, HORIZONTAL; MOLECULAR TYPING; PLASMIDS; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS;

EID: 85014701268     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.12.009     Document Type: Article

References (35)

1. [1] Schultsz, C., Geerlings, S., Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy. Drugs 72 (2012), 1–16.
2. [2] Falagas, M.E., Giannopoulou, K.P., Kokolakis, G.N., Rafailidis, P.I., Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin Infect Dis 46 (2008), 1069–1077.
3. [3] Okazaki, M., Suzuki, K., Asano, N., Araki, K., Shukuya, N., Egami, T., et al. Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay. J Infect Chemother 8 (2002), 37–42.
4. [4] Takahashi, K., Kanno, H., Synergistic activities of combinations of β-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 26 (1984), 789–791.
5. [5] Hou, J., Yang, X., Zeng, Z., Lv, L., Yang, T., Lin, D., et al. Detection of the plasmid-encoded fosfomycin resistance gene fosA3 in Escherichia coli of food-animal origin. J Antimicrob Chemother 68 (2013), 766–770.
6. [6] Hou, J., Huang, X., Deng, Y., He, L., Yang, T., Zeng, Z., et al. Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China. Antimicrob Agents Chemother 56 (2012), 2135–2138.
7. CTX-M-55/-14/-65 in Escherichia coli from chickens in China. Front Microbiol, 5, 2014, 688.
8. [8] Lin, D., Chen, S., First detection of conjugative plasmid-borne fosfomycin resistance gene fosA3 in Salmonella isolates of food origin. Antimicrob Agents Chemother 59 (2015), 1381–1383.
9. [9] Lee, S.Y., Park, Y.J., Yu, J.K., Jung, S., Kim, Y., Jeong, S.H., et al. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother 67 (2012), 2843–2847.
10. [10] Flores-Mireles, A.L., Walker, J.N., Caparon, M., Hultgren, S.J., Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13 (2015), 269–284.
11. SHV-12, and rmtB from an epidemic Klebsiella pneumoniae sequence type 11 strain in China. Antimicrob Agents Chemother 60 (2015), 1343–1348.
12. CMY-16, and fosA3 in a Salmonella enterica serovar Corvallis strain isolated from a migratory wild bird in Germany. Antimicrob Agents Chemother 59 (2015), 6597–6600.
13. [13] Weisburg, W.G., Barns, S.M., Pelletier, D.A., Lane, D.J., 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173 (1991), 697–703.
14. [14] Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. Document M100-S24, 2014, CLSI, Wayne (PA).
15. [15] Li, B., Zhang, Y., Wei, J., Shao, D., Liu, K., Shi, Y., et al. Characterization of a novel small plasmid carrying the florfenicol resistance gene floR in Haemophilus parasuis. J Antimicrob Chemother 70 (2015), 3159–3161.
16. [16] Liu, J.H., Wei, S.Y., Ma, J.Y., Zeng, Z.L., Lu, D.H., Yang, G.X., et al. Detection and characterisation of CTX-M and CMY-2 β-lactamases among Escherichia coli isolates from farm animals in Guangdong Province of China. Int J Antimicrob Agents 29 (2007), 576–581.
17. [17] Zhao, J., Chen, Z., Chen, S., Deng, Y., Liu, Y., Tian, W., et al. Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment. Antimicrob Agents Chemother 54 (2010), 4219–4224.
18. [18] Tenover, F.C., Arbeit, R.D., Goering, R.V., Mickelsen, P.A., Murray, B.E., Persing, D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995), 2233–2239.
19. [19] Dissanayake, D.R., Octavia, S., Lan, R., Population structure and virulence content of avian pathogenic Escherichia coli isolated from outbreaks in Sri Lanka. Vet Microbiol 168 (2014), 403–412.
20. [20] Clermont, O., Bonacorsi, S., Bingen, E., Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66 (2000), 4555–4558.
21. [21] Carattoli, A., Bertini, A., Villa, L., Falbo, V., Hopkins, K.L., Threlfall, E.J., Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63 (2005), 219–228.
22. [22] Garcia-Fernandez, A., Carattoli, A., Plasmid double locus sequence typing for IncHI2 plasmids, a subtyping scheme for the characterization of IncHI2 plasmids carrying extended-spectrum β-lactamase and quinolone resistance genes. J Antimicrob Chemother 65 (2010), 1155–1161.
23. [23] Villa, L., Garcia-Fernandez, A., Fortini, D., Carattoli, A., Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 65 (2010), 2518–2529.
24. [24] Liu, S.L., Hessel, A., Sanderson, K.E., Genomic mapping with I-CeuI, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria. Proc Natl Acad Sci USA 90 (1993), 6874–6878.
25. CTX-M-65, fosA3 and rmtB on conjugative IncFII plasmids in Escherichia coli ST117 isolates from chicken. J Med Microbiol 63 (2014), 485–488.
26. [26] Bergeron, C.R., Prussing, C., Boerlin, P., Daignault, D., Dutil, L., Reid-Smith, R.J., et al. Chicken as reservoir for extraintestinal pathogenic Escherichia coli in humans, Canada. Emerg Infect Dis 18 (2012), 415–421.
27. [27] Mora, A., Lopez, C., Herrera, A., Viso, S., Mamani, R., Dhabi, G., et al. Emerging avian pathogenic Escherichia coli strains belonging to clonal groups O111:H4-D-ST2085 and O111:H4-D-ST117 with high virulence-gene content and zoonotic potential. Vet Microbiol 156 (2012), 347–352.
28. [28] Fang, L., Li, X., Li, L., Li, S., Liao, X., Sun, J., et al. Co-spread of metal and antibiotic resistance within ST3-IncHI2 plasmids from E. coli isolates of food-producing animals. Sci Rep, 6, 2016, 25312.
29. [29] Zhi, C., Lv, L., Yu, L.F., Doi, Y., Liu, J.H., Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 16 (2016), 292–293.
30. [30] Doumith, M., Godbole, G., Ashton, P., Larkin, L., Dallman, T., Day, M., et al. Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales. J Antimicrob Chemother 71 (2016), 2300–2305.
31. [31] Jacobsen, S.M., Stickler, D.J., Mobley, H.L.T., Shirtliff, M.E., Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 21 (2008), 26–59.
32. [32] Song, W., Kim, J., Bae, I.K., Jeong, S.H., Seo, Y.H., Shin, J.H., et al. Chromosome-encoded AmpC and CTX-M extended-spectrum β-lactamases in clinical isolates of Proteus mirabilis from Korea. Antimicrob Agents Chemother 55 (2011), 1414–1419.
33. CTX-M-15 associated with ISEcp1 in Proteus mirabilis and Morganella morganii isolated at the military hospital of Tunis, Tunisia. J Med Microbiol 61 (2012), 1286–1289.
34. [34] Wenner, J.J., Rettger, L.F., A systematic study of the Proteus group of bacteria. J Bacteriol, 4, 1919, 331.
35. [35] Jayol, A., Janvier, F., Guillard, T., Chau, F., Mérens, A., Robert, J., et al. qnrA6 genetic environment and quinolone resistance conferred on Proteus mirabilis. J Antimicrob Chemother 71 (2016), 903–908.